Clinical Trial

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 750 mg administration in patients with Cholesterol gallstone (radiolucent gallstones)
Protocol Amendment History 3 changes
notable Trial sites expanded: 6 -> 13 locations 2026-07-30
notable Primary completion pushed: 2026-06 -> 2027-11-10 2026-07-30
minor Completion pushed: 2026-06 -> 2028-06-13 2026-07-30
Trial Details
NCT Number NCT07005752
Lead Sponsor Myungmoon Pharma. Co. Ltd.
Conditions Cholesterol Cholelithiasis
Enrollment 484 participants
Start Date 2025-07-28
Primary Completion 2027-11-10 (estimated)
Study Completion 2028-06-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-29